Is voice personalization suitable and useful for ALS patients?

Andrea Calvo; Piero Cosi; Giulio Paci; Valentina Pasian; Giacomo Sommavilla; Fabio Tesser

doi:10.17469/O2103AISV000024

Autori

Andrea Calvo Dipartimento di Neuroscienze “Rita Levi Montalcini”, Università degli Studi di Torino, CRESLA – Centro Regionale Esperto per la Sclerosi Laterale Amiotrofica, A.O.U. Città della Salute e della Scienza di Torino
Piero Cosi Istituto di Scienze e Tecnologie della Cognizione del CNR (ISTCCNR), Padova
Giulio Paci MIVOQ, Bassano del Grappa
Valentina Pasian CRESLA – Centro Regionale Esperto per la Sclerosi Laterale Amiotrofica, A.O.U. Città della Salute e della Scienza di Torino
Giacomo Sommavilla MIVOQ, Bassano del Grappa
Fabio Tesser MIVOQ, Bassano del Grappa

DOI:

https://doi.org/10.17469/O2103AISV000024

Parole chiave:

ALS, Voice Personalization, TTS

Abstract

This study arises from the collaboration between MIVOQ, the ALS association CRESLA, and CNR, and it is still in an early preparatory and development phase. The aim of this experimental study is that of verifying the impact on the quality of life of patients and of his family members who use a speech synthesizer able to replicate the vocal timbre of the user’s voice. The specific objectives of this work include understanding how “Your Digital Voice” is suitable and useful for ALS patients.